Word

CRPHAGE

Status

Dead

Status Code

606

Status Date

Monday, January 8, 2024

Serial Number

97169063

Mark Type

4000

Filing Date

Monday, December 13, 2021

Published for Opposition

Tuesday, April 11, 2023

Abandoned Date

Monday, January 8, 2024

Trademark Owner History

Locus Biosciences, Inc. - Owner At Publication

Classifications

5 Pharmaceutical preparations for targeting and destroying bacteria; pharmaceutical preparations for the treatment of antibiotic-resistant bacterial infections and microbiome-related disorders; pharmaceutical preparations for use in the field of engineered bacteriophage; pharmaceuticals designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, namely, cancer, autoimmune and inflammatory diseases namely, transplantation and delayed-type hypersensitivity, respiratory diseases, gastrointestinal diseases, cardiovascular and metabolic diseases, pathogen infections, musculoskeletal diseases, ophthalmologic and dermatologic diseases, genitourinary diseases, degenerative diseases, and orphan diseases

Trademark Events

Jan 8, 2024

Abandonment Notice E-Mailed - No Use Statement Filed

Jan 8, 2024

Abandonment - No Use Statement Filed

Jun 6, 2023

Noa E-Mailed - Sou Required From Applicant

Apr 11, 2023

Official Gazette Publication Confirmation E-Mailed

Apr 11, 2023

Published For Opposition

Mar 22, 2023

Notification Of Notice Of Publication E-Mailed

Mar 7, 2023

Approved For Pub - Principal Register

Mar 7, 2023

Examiner's Amendment Entered

Mar 7, 2023

Notification Of Examiners Amendment E-Mailed

Mar 7, 2023

Examiners Amendment E-Mailed

Mar 7, 2023

Examiners Amendment -Written

Sep 21, 2022

Notification Of Non-Final Action E-Mailed

Sep 21, 2022

Non-Final Action E-Mailed

Sep 21, 2022

Non-Final Action Written

Sep 20, 2022

Assigned To Examiner

Dec 16, 2021

New Application Office Supplied Data Entered

Dec 16, 2021

New Application Entered